Belgium vs Middle East, North Africa, Afghanistan & Pakistan: Immunization, HepB3
Immunization, HepB3 over time
- Belgium
- Middle East, North Africa, Afghanistan & Pakistan
How they compare
Belgium currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes Belgium's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
The two have swapped places 3 times across 28 shared years of data; in 1997 it was Middle East, North Africa, Afghanistan & Pakistan ahead.
Belgium ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 24th of 188 countries.
Across the 4 decades both report, Belgium averaged higher in 3 and Middle East, North Africa, Afghanistan & Pakistan in 1.
Head to head by decade
| Decade | Belgium | Middle East, North Africa, Afghanistan & Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 26.3% | 34.5% | 8.2% | Middle East, North Africa, Afghanistan & Pakistan |
| 2000s | 76.8% | 63.5% | 13.3% | Belgium |
| 2010s | 97.4% | 80.5% | 16.9% | Belgium |
| 2020s | 97.0% | 83.4% | 13.6% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Belgium or Middle East, North Africa, Afghanistan & Pakistan?
- Belgium, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between Belgium and Middle East, North Africa, Afghanistan & Pakistan?
- 12.6%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Middle East, North Africa, Afghanistan & Pakistan?
- 28 years are reported by both, from 1997 to 2024.
- How do Belgium and Middle East, North Africa, Afghanistan & Pakistan rank globally for immunization, hepb3?
- Belgium ranks 26th and Middle East, North Africa, Afghanistan & Pakistan ranks 24th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.